ClinVar Miner

Submissions for variant NM_080425.4(GNAS):c.98C>A (p.Ala33Asp)

gnomAD frequency: 0.00001  dbSNP: rs746548577
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000578725 SCV000681060 uncertain significance not provided 2017-11-07 criteria provided, single submitter clinical testing The A33D variant in the GNAS gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The A33D variant is observed in 5/8264 (0.06%) alleles from individuals of Ashkenazi Jewish background in large population cohorts (Lek et al., 2016). The A33D variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. In-silico analyses, including protein predictors and evolutionary conservation, are inconsistent in their assessment as to whether or not the variant is damaging. We interpret A33D as a variant of uncertain significance.
Fulgent Genetics, Fulgent Genetics RCV002491150 SCV002781019 uncertain significance McCune-Albright syndrome; Pseudohypoparathyroidism type 1C; Pseudohypoparathyroidism type 1B; Pseudopseudohypoparathyroidism; Progressive osseous heteroplasia; Pituitary adenoma 3, multiple types; ACTH-independent macronodular adrenal hyperplasia 1; Pseudohypoparathyroidism type I A 2021-12-10 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004527666 SCV004106694 uncertain significance GNAS-related disorder 2023-09-08 criteria provided, single submitter clinical testing The GNAS c.98C>A variant is predicted to result in the amino acid substitution p.Ala33Asp. This variant is pre-coding in the primary transcript NM_000516.5. To our knowledge, this variant has not been reported in the literature. To our knowledge, only large deletions in this region of the gene are conclusively pathogenic for pseudohypoparathyroidism type-Ib (PHP-Ib) due to methylation defects (Turan and Bastepe. 2015. PubMed ID: 25851935). Although, in some studies single nucleotide variants (SNVs) within this region have been reported in related diseases, the pathogenicity of these variants is still uncertain (see for example in Table 3 of Long et al. 2018. PubMed ID: 30022773). This variant is reported in 0.059% of alleles in individuals of Ashkenazi Jewish descent in gnomAD (http://gnomad.broadinstitute.org/variant/20-57428418-C-A). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.